IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

Kobayashi, T; Okamoto, S; Hisamatsu, T; Kamada, N; Chinen, H; Saito, R; Kitazume, M T; Nakazawa, A; Sugita, A; Koganei, K; Isobe, K; Hibi, T
December 2008
Gut;Dec2008, Vol. 57 Issue 12, p1682
Academic Journal
Background: A novel T helper (Th) cell lineage, Th17, that exclusively produces the proinflammatory cytokine interleukin 17 )1L17) has been reported to play important roles in various inflammatory diseases. 1L23 is also focused upon for its potential to promote 1h17. Here, the roles of the lL23/IL1 7 axis in inflammatory bowel diseases such as ulcerative colitis (UC) and Crohn's disease (CD) were investigated. Methods: Mucosal samples were obtained from surgically resected specimens (controls, n = 12; UC, n = 17; CD, n = 22). 1L17 production by isolated peripheral blood (PB) and lamina propria )LP) CD4~ cells was examined. Quantitative PCR amplification was performed to determine the mRNA expression levels of 1L17, interferon y (IFN'y), 1L23 receptor )1L23R) and retinoic acid-related orphan receptor -y (RORC) in LP CD4~ cells, and 1L12 family members, such as ILl 2p40, ILl 2p35 and lL23p19, in whole mucosal specimens. The effects of exogenous 1L23 on ILl 7 production by LP CD4~ cells were also examined. Results: 1L17 production was higher in LP CD4~ cells than in PB. Significant 1L17 mRNA upregulation in LP CD4~ cells was found in UC, while IFN-y was increased in CD. IL23R and RORC were upregulated in LP CD4~ cells isolated from both UC and CD. 1L17 production was significantly increased by 1L23 in LP CD4~ cells from UC but not CD. Upregulated lL23p19 mRNA expression was correlated with 1L17 in UC and IFN-y in CD. Conclusions: lL23 may play important roles in controlling the differential Thl/Thl 7 balance in both UC and CD, althouqh Th17 cells may exist in both diseases.


Related Articles

  • Mucosal cytokine network in inflammatory bowel disease. Andoh, Akira; Yagi, Yuhki; Shioya, Makoto; Nishida, Atsushi; Tsujikawa, Tomoyuki; Fujiyama, Yoshihide; Costa, Francesco; Das, Kiron M. // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5154 

    Inflammatory bowel disease (IBD), ulcerative colitis (UC) and Crohn's disease (CD) are characterized by ongoing mucosal inflammation in which dysfunction of the host immunologic response against dietary factors and commensal bacteria is involved. The chronic inflammatory process leads to...

  • IL-23: a master regulator in Crohn disease. Neurath, Markus F. // Nature Medicine;Jan2007, Vol. 13 Issue 1, p26 

    The article focuses on the studies in pro-inflammatory cytokine interleukin (IL)-23. The common gastrointestinal diseases are the chronic inflammatory bowel diseases ulcerative colitis and Crohn's disease. The article suggests that studies should focus on the new IL-23 which performs a unique...

  • Evolving knowledge and therapy of inflammatory bowel disease. Korzenik, Joshua R.; Podolsky, Daniel K. // Nature Reviews Drug Discovery;Mar2006, Vol. 5 Issue 3, p197 

    With recent advances in the understanding of its pathophysiology, inflammatory bowel disease has become a very active area for the development of novel therapeutic agents. New targets for biologics include cytokines involved in T-cell activation, with antibodies directed against IL-12 and...

  • The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. Andersen, Vibeke; Ernst, Anja; Christensen, Jane; Østergaard, Mette; Jacobsen, Bent A.; Tjønneland, Anne; Krarup, Henrik B.; Vogel, Ulla // BMC Medical Genetics;2010, Vol. 11, p82 

    Background: Crohns disease (CD) and ulcerative colitis (UC) are characterized by a dysregulated inflammatory response to normal constituents of the intestinal flora in the genetically predisposed host. Heme oxygenase-1 (HO-1/ HMOX1) is a powerful anti-inflammatory and anti-oxidant enzyme,...

  • Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn’s disease in Japanese patients. Yamazaki, Keiko; Onouchi, Yoshihiro; Takazoe, Masakazu; Kubo, Michiaki; Nakamura, Yusuke; Hata, Akira // Journal of Human Genetics;Jul2007, Vol. 52 Issue 7, p575 

    Inflammatory bowel diseases, Crohn’s disease (CD) and ulcerative colitis are characterised by chronic transmural, segmental and typically granulomatous inflammation of the gut. Each has a peak age of onset in the second to fourth decades of life and prevalence has been increasing...

  • Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease. Ogata, Haruhiko; Hibi, Toshifumi // Current Pharmaceutical Design;May2003, Vol. 9 Issue 14, p1107 

    Although the pathogenesis of inflammatory bowel disease (IBD) remains elusive, it appears that there is chronic activation of the immune and inflammatory cascade in genetically susceptible individuals. Current disease management guidelines have therefore focused on the use of anti-inflammatory...

  • Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. Torres, M. I.; Riós, A.; A. Crusius, J. Bart // World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p1972 

    Although the aetiology of inflammatory bowel disease (IBD) remains unknown, the pathogenesis is gradually being unravelled, seeming to be the result of a combination of environmental, genetic, and immunological factors in which an uncontrolled immune response within the intestinal lumen leads to...

  • Interleukin-23 and Th17 Cells in the Control of Gut Inflammation. Monteleone, Ivan; Pallone, Francesco; Monteleone, Giovanni // Mediators of Inflammation;2009, Vol. 2009, Special section p1 

    Crohn's Disease and Ulcerative Colitis, the major forms of inflammatory bowel diseases (IBDs) in humans, have been traditionally associated with exaggerated and poorly controlled T helper (Th) type 1 or Th2 cell response, respectively. More recent studies have, however, shown that IBDs are also...

  • Fenotipo e historia natural de la enfermedad inflamatoria intestinal en un centro de referencia en Medell�n-Colombia. Ba�os, Fabi�n Juliao; V�lez, Mario Hern�n Ruiz; Arango, Jos� Fernando Fl�rez; G�mez, Jorge Hernando Donado; Zuluaga, Juan Ignacio Mar�n; Arango, Claudia Monsalve; G�mez, Carlos Andr�s Jim�nez; Zapata, Yineth Agudelo; Velayos, Fernando S. // Revista Colombiana de Gastroenterolog�a;Jul2012, Vol. 25 Issue 3, p240 

    Worldwide the frequencies of inflammatory bowel disease, ulcerative colitis and Crohn�s disease have all increased. In our own environment it has become necessary to establish the epidemiology of these entities and to determine their clinical and endoscopic behavior. Methodology: This is a...


Read the Article


Sign out of this library

Other Topics